Cabaletta Bio, Inc. Common Stock (CABA) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for CABA. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 134 institutions reported holding CABA, with 157.9 million shares worth $490.4 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| T. Rowe Price | 23,288,581 | $72M | INCREASED |
| Jennison Associates | 20,033,730 | $62M | INCREASED |
| Bain Capital Life Sciences Investors | 17,241,445 | $54M | INCREASED |
| BlackRock | 10,754,701 | $33M | INCREASED |
| Vanguard | 9,801,946 | $30M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Cabaletta Bio, Inc. Common Stock on SentiSense.